AIMS/HYPOTHESIS: Evidence that the beta cells of human patients with type 1 diabetes can be infected with enterovirus is accumulating, but it remains unclear whether such infections occur at high frequency and are important in the disease process. We have now assessed the prevalence of enteroviral capsid protein vp1 (vp1) staining in a large cohort of autopsy pancreases of recent-onset type 1 diabetic patients and a range of controls. METHODS: Serial sections of paraffin-embedded pancreatic autopsy samples from 72 recent-onset type 1 diabetes patients and up to 161 controls were immunostained for insulin, glucagon, vp1, double-stranded RNA activated protein kinase R (PKR) and MHC class I. RESULTS: vp1-immunopositive cells were detected in multiple islets of 44 out of 72 young recent-onset type 1 diabetic patients, compared with a total of only three islets in three out of 50 neonatal and paediatric normal controls. vp1 staining was restricted to insulin-containing beta cells. Among the control pancreases, vp1 immunopositivity was also observed in some islets from ten out of 25 type 2 diabetic patients. A strong correlation was established between islet cell vp1 positivity and PKR production in insulin-containing islets of both type 1 and type 2 diabetic patients, consistent with a persistent viral infection of the islets. CONCLUSIONS/ INTERPRETATION: Immunoreactive vp1 is commonly found in the islets of recent-onset type 1 diabetes patients, but only rarely in normal paediatric controls. vp1 immunostaining was also observed in some islets of type 2 diabetes patients, suggesting that the phenomenon is not restricted to type 1 diabetes patients.
AIMS/HYPOTHESIS: Evidence that the beta cells of humanpatients with type 1 diabetes can be infected with enterovirus is accumulating, but it remains unclear whether such infections occur at high frequency and are important in the disease process. We have now assessed the prevalence of enteroviral capsid protein vp1 (vp1) staining in a large cohort of autopsy pancreases of recent-onset type 1 diabeticpatients and a range of controls. METHODS: Serial sections of paraffin-embedded pancreatic autopsy samples from 72 recent-onset type 1 diabetespatients and up to 161 controls were immunostained for insulin, glucagon, vp1, double-stranded RNA activated protein kinase R (PKR) and MHC class I. RESULTS: vp1-immunopositive cells were detected in multiple islets of 44 out of 72 young recent-onset type 1 diabeticpatients, compared with a total of only three islets in three out of 50 neonatal and paediatric normal controls. vp1 staining was restricted to insulin-containing beta cells. Among the control pancreases, vp1 immunopositivity was also observed in some islets from ten out of 25 type 2 diabeticpatients. A strong correlation was established between islet cell vp1 positivity and PKR production in insulin-containing islets of both type 1 and type 2 diabeticpatients, consistent with a persistent viral infection of the islets. CONCLUSIONS/ INTERPRETATION: Immunoreactive vp1 is commonly found in the islets of recent-onset type 1 diabetespatients, but only rarely in normal paediatric controls. vp1 immunostaining was also observed in some islets of type 2 diabetespatients, suggesting that the phenomenon is not restricted to type 1 diabetespatients.
Authors: P Ylipaasto; B Kutlu; S Rasilainen; J Rasschaert; K Salmela; H Teerijoki; O Korsgren; R Lahesmaa; T Hovi; D L Eizirik; T Otonkoski; M Roivainen Journal: Diabetologia Date: 2005-07-01 Impact factor: 10.122
Authors: O Cinek; E Witsø; S Jeansson; T Rasmussen; P Drevinek; T Wetlesen; J Vavrinec; B Grinde; K S Rønningen Journal: J Clin Virol Date: 2006-01 Impact factor: 3.168
Authors: K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf Journal: Proc Natl Acad Sci U S A Date: 1992-01-01 Impact factor: 11.205
Authors: Karin Klingel; Martina Sauter; C Thomas Bock; Gudrun Szalay; Jens-Jörg Schnorr; Reinhard Kandolf Journal: Med Microbiol Immunol Date: 2003-08-14 Impact factor: 3.402
Authors: M-L Simonen-Tikka; M Pflueger; P Klemola; C Savolainen-Kopra; T Smura; S Hummel; S Kaijalainen; K Nuutila; O Natri; M Roivainen; A-G Ziegler Journal: Diabetologia Date: 2011-09-20 Impact factor: 10.122
Authors: Hanna Viskari; Sami Oikarinen; Sanna Hoppu; Tytti Vuorinen; Heini Huhtala; Jorma Toppari; Riitta Veijola; Jorma Ilonen; Mikael Knip; Heikki Hyöty Journal: Diabetologia Date: 2017-09-02 Impact factor: 10.122
Authors: Peter A Gottlieb; Aimon K Alkanani; Aaron W Michels; Eli C Lewis; Leland Shapiro; Charles A Dinarello; Danny Zipris Journal: J Clin Endocrinol Metab Date: 2014-02-14 Impact factor: 5.958